one of the university's flagships
Cancer never ceases to gain ground globally, and it is more
important than ever to find a way to reverse this trend.
At the start of the millennium, Rector Robert Lacroix sought
to position Université de montréal as one of the world leaders
in cancer research. He was right to do so. Today, the Institute
for Research in Immunology and Cancer (IRIC) has risen to
the challenge and stands out, particularly for its implementation
of the first real anticancer drug discovery chain in an academic
setting in Canada.
Through innovation, bold thinking and the expertise of its
investigators, IRIC makes an extraordinary contribution to our
prestige as an institution and stands as one of our flagships.
A crazy dream
The creation of IRIC in 2003 was the most daring project
undertaken during my time as rector of Université de montréal.
Even in my wildest dreams, I never imagined that the Institute
would acquire such a degree of excellence in so short a time.
This excellence was acquired, first and foremost, thanks to its
exceptional team as well as the support of Université de montréal
and the many people who signed on to the project.
This bridging of the academic and business worlds carries over
to IRIC's Board of Directors. Its members, who are all convinced
of the Institute's key importance, are not content just to spread
the good news of its developments and discoveries: they also help
keep it on track, by regularly reviewing its strategic plan and by
helping to secure the funding that will support it. In this regard,
IRIC's first fundraising campaign, which I co-chaired with
marcel Dutil, chairman of the Board and CEO of the Canam Group,
can be termed historic: since the start of the campaign, we have
On the eve of a new large fundraising campaign at Université
de montréal, there is no doubt that its development and
renown remain among our top priorities. And we hope that IRIC
will garner all the financial support it needs to effectively carry
out its mission.
Lastly, I would like to use the publication of this first activity
report to thank Dr. Guy sauvageau and IRIC's investigators, staff
and students as well as the members of its Board of Directors
for their devoted work.
guy breton, m.d., f.R.C.p.(c)
Rector, Université de montréal
collected a little over $14 million. A true achievement for such a
young research centre and one that is still relatively unknown to
the general public! On this point, I would particularly like to thank
the marcelle and Jean Coutu Foundation for giving the campaign
an initial boost with an exceptional donation to IRIC of $5 million.
IRIC has been one of the finest achievements in which I have
played a role in my career. And each time a major development
occurs or a discovery is made here, I view it as a gift, a very
personal reward. I even dare to imagine that one day, one of the
Institute's investigators will receive the ultimate award: a Nobel
prize. A crazy dream? Perhaps not as crazy as one may think.
Robert lacroix, ph.d., Cm, oQ, msRC (fRsC)
Chairman of IRIC's Board of Directors